CMS proposes delaying drugmaker rule days after PhRMA sues

The Centers for Medicare and Medicaid Services has proposed to delay a rule requiring drugmakers to report their multiple best prices, including discounts offered to consumers, under Medicaid's drug rebate program.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive